Medical Technology

The National Medical Commission has asserted that the de-notification of the Maintenance of Standards of Medical Education Regulations, 2023 will not dilute prescribed standards of medical education and are intended to remove overlapping procedures. The Commission, which is the statutory body for medical education in the country, had on October 14 denotified the Maintenance of Standards of Medical Education Regulations (MSMER-2023). The denotification "does not, in any manner, dilute the prescribed standards of medical education or the regulatory oversight exercised by NMC," a statement by the Commission said. Under the National Medical Commission Act, 2019, the Undergraduate Medical Education Board (UGMEB) and Postgraduate Medical Education Board (PGMEB) are primarily entrusted with prescribing academic standards, minimum requirements and educational norms. The Medical Assessment and Rating Board (MARB), under Section 26 of the Act is specifically empowered to assess and inspect .

Department of Pharmaceuticals invites stakeholder comments on proposed additions and deletions to the list of medical devices exempted from Global Trade Enquiry requirements

China is pushing to upgrade its economy and reshape its global image from just a manufacturing hub into a provider of high-value services, and demand for medical tourism is surging

India's overall MedTech opportunity could expand more than fourfold to $83-89 billion by 2035, driven by rising domestic demand, exports and contract manufacturing

Medtech firms are split over draft norms on standardised testing fees, with some backing transparency and others warning of higher compliance burden for low-risk devices

Smartphone cameras enhance images for aesthetics by adjusting colour, light and detail, but these automatic edits can distort features and compromise medical accuracy during remote consultations

Alkem Laboratories' devices arm to acquire controlling stake in Swiss cardiac implant maker, marking entry into global structural heart segment

After reporting an 80% revenue jump and EBITDA positivity in Q2FY26, Medikabazaar plans 40% annual growth over the next three years, even as it navigates a high-profile boardroom dispute

AIMED said GST changes could hurt domestic medtech competitiveness and tilt the market towards imports, urging balanced tax slabs, refund reforms, and a higher Health Cess

Medtronic, an Ireland-based healthcare company that develops medical technology, recently experimented with its Hugo robot, which assisted in performing 137 real surgeries

According to the Department of Pharmaceuticals' annual report for 2024-25, India imported medical devices worth $8.1 billion, while exports stood at $3.7 billion in the financial year 2023-24 (FY24)

Industry also faces shortages of component suppliers and talent, particularly in research and development

Government and industry should work together to bring down import dependence in the medical device segment to below 50 per cent over the next five years, Department of Pharmaceuticals Secretary Arunish Chawla said on Tuesday. Highlighting the critical need to focus on quality to ensure that India becomes globally competitive, he noted that the government is in the process of formulating standards for over 2,000 medical devices being produced in the country in order to make them globally competitive. "Right now our med-tech sector is 75-80 per cent import dependent. In the next five years, we want to bring down this import dependence to less than 50 per cent," Chawla said while speaking to reporters here on the sidelines of an industry event to formulate better policies for the sector. Chawla noted that deliberations were also held during the Meditech Stackathon 2024 to scale the medical device exports to match the level of imports of such articles into the country, he added. Stress

Speaking on the subject, Leena Dalal, senior veterinary surgeon and oncologist MaxPetZ said that this would be the first time in India that 3D Printing is being used to treat animals

The products slated for export include positron emission tomography-computed tomography (PET-CT) used for cancer diagnosis, CT, and magnetic resonance imaging (MRI) coils

Clinisys holds a leadership position in the clinical laboratory information systems market, with a 19 per cent share of the market

The med-tech firm also collaborated with the Medanta group of hospitals to launch Tele-ICU services in India as Medanta e-ICU project

Domestic medical devices industry should come up with cutting-edge technologies to gain leadership across global markets, NITI Aayog member (Health) Dr VK Paul said on Thursday. Speaking at an event here, he also asked the industry to initiate ways to tap AI for their respective medical devices. Paul noted that the government has already taken a lot of steps in policy terms and now it is the turn of the industry to move ahead. "We believe that we need frugal innovation, but we also strongly believe that India must do cutting-edge innovations...for our leadership in industry, for our leadership in the world," Paul said. The industry needs to address the cutting edge, breakthroughs, he said, adding that nothing much has been achieved after technologies like MRI (Magnetic Resonance Imaging). "That means the space is open for us to catch up and leapfrog in the direction of new ideas, new solutions, and disruptive technologies that should emanate from India," Paul added. He noted that

According to the Global Trade Research Initiative (GTRI) report on August 2023, the Indian medical devices industry has the potential to expand from $12 billion to $50 billion by 2030

Seek a separate 'Medical Devices Act' distinct from the drug regulations Bill